Calcium Carbonate Encapsulation for Freeze-Dried Probiotic Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing probiotic products face challenges in reaching the intestines safely while maintaining viability due to gastric acid and bile acid, and conventional multi-coating methods are costly and prone to deformation during freeze-drying.

Innovation Solution

Encapsulating probiotics with calcium carbonate to enhance intestinal reach rate, stability during freeze-drying, and storage stability, using a method that includes culturing probiotics, mixing with calcium and carbonate sources, and freeze-drying to form probiotics encapsulated with calcium carbonate (PEC).

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional multi-coating methods are used to protect probiotics, then probiotic protection is improved, but production cost increases and coating deformation occurs during freeze-drying

Engineering Contradiction:
Improveprobiotic protectionVSAvoidmulti-coating process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The invention divides the protection function into two distinct components: calcium carbonate provides structural protection against mechanical stress during freeze-drying, while alginate provides chemical protection against gastric and bile acids. This segmentation allows each material to optimize its specific function rather than requiring multiple layers of the same material.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses a composite encapsulation system combining calcium carbonate and alginate in a core-shell structure. Calcium carbonate forms the inner core providing structural integrity, while alginate forms the outer shell providing chemical resistance. This composite approach resolves the contradiction by achieving comprehensive protection through material complementarity rather than repetitive coating.

Inventive Principle:
Principle #40Composite materials

2Reliability

If conventional multi-coating methods are used to protect probiotics, then probiotic protection is improved, but production cost increases

Engineering Contradiction:
Improveprobiotic protectionVSAvoidproduction cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The invention merges the structural protection function and chemical protection function into a single encapsulation step. By combining calcium carbonate and alginate in one process rather than applying multiple sequential coating layers, the production cost is reduced while maintaining comprehensive probiotic protection.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The calcium carbonate particles naturally provide structural protection without requiring additional coating layers. The alginate then self-organizes around the calcium carbonate core through ionic crosslinking, creating the protective shell automatically. This self-organizing process reduces manufacturing complexity and cost compared to controlled multi-step coating procedures.

Inventive Principle:
Principle #25Self-service

3Ease of manufacture

If probiotics are administered directly without encapsulation, then production cost is reduced, but probiotics are damaged by gastric acid and bile acid

Engineering Contradiction:
Improveproduction costVSAvoidgastric acid and bile acid damage
Core Design Contradiction:
Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The alginate shell acts as an intermediary barrier between the probiotics and the harmful gastric and bile acids. This intermediate layer allows the probiotics to remain in their simple, uncoated state (maintaining low cost) while the alginate mediator provides the necessary chemical protection during passage through the digestive system.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Ease of manufacture

If simple encapsulation is used to reduce cost, then production cost is reduced, but intestinal reach rate is insufficient

Engineering Contradiction:
Improveproduction costVSAvoidintestinal reach rate
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The invention applies local quality by providing different types of protection at different locations: calcium carbonate provides local structural protection at the core level against mechanical stress, while alginate provides local chemical protection at the shell level against acids. This localized protection strategy achieves high intestinal reach rate without requiring complex multi-layer coating throughout the entire structure.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Improves intestinal reach rate and probiotic survival during freeze-drying, with high encapsulation yield and stability, achieving 8 to 11 Log CFU/g intestine-reaching cell count and 96% to 100% encapsulation yield.

Implementation Method 1

the calcium carbonate reacts with bile and is converted into hydroxyapatite

Methodology Applied
Scientific EffectChemical reaction: Chemical Bonding

Implementation Method 2

a method for preparing the probiotics encapsulated with calcium carbonate

Methodology Applied
Scientific EffectFreeze-drying: Freeze Drying

Data Source

PatentUS20250295599A1Probiotics encapsulated with calcium carbonate and method for preparing same
Publication Date: 2025.09.25 KOREA MARITIME UNIV IND ACADEMIC COOPERATION FOUND
  • US20250295599A1 patent drawing
  • US20250295599A1 patent drawing
  • US20250295599A1 patent drawing

AI summary

Probiotics encapsulated with calcium carbonate, includes: calcium carbonate; and probiotics. The probiotics encapsulated with calcium carbonate have a particle size of 0.9 to 9.2 μm. The probiotics encapsulated with calcium carbonate have a calcium carbonate content of 17% to 98%. The probiotics encapsulated with calcium carbonate have an intestine-reaching cell count of 8 to 11 Log CFU/g. The calcium carbonate reacts with bile and is converted into hydroxyapatite.